Gds Wealth Management Astrazeneca PLC Transaction History
Gds Wealth Management
- $1.48 Billion
- Q3 2025
A detailed history of Gds Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Gds Wealth Management holds 4,859 shares of AZN stock, worth $434,394. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,859
Previous 5,147
5.6%
Holding current value
$434,394
Previous $378,000
1.59%
% of portfolio
0.03%
Previous 0.03%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,517Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...